CAPTRUST Financial Advisors’s Korsana Biosciences KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-2,090
Closed -$60.3K – 2650
2023
Q2
$60.3K Hold
2,090
– – ﹤0.01% 2417
2023
Q1
$127K Buy
+2,090
New +$185K ﹤0.01% 2129

Other funds holding KRSA

CAPTRUST Financial Advisors's KRSA Position: Q3 2023 in Review

CAPTRUST Financial Advisors sold out of Korsana Biosciences (KRSA) in Q3 2023, closing a stake of 2,090 shares — an estimated $60.3K sold.

CAPTRUST Financial Advisors first reported a position in KRSA in Q1 2023 and held it in 2 quarters. The position peaked at $127K in Q1 2023. 15 funds tracked by Wall St. Rank hold KRSA as of Q3 2023.

  • CAPTRUST Financial Advisors reported no remaining Korsana Biosciences position as of Q3 2023 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 2,090 Korsana Biosciences shares in Q3 2023, an estimated $60.3K.
  • CAPTRUST Financial Advisors first reported a position in Korsana Biosciences in Q1 2023 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's Korsana Biosciences position peaked at $127K in Q1 2023.
  • 15 funds tracked by Wall St. Rank held Korsana Biosciences as of Q3 2023.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.